Pharmaceutical industry
As the holiday season approaches, a growing number of U.S. governors and officials are taking steps to expand access to COVID-19 boosters, despite federal guidance that only recommends them for certain high-risk groups. California made the first move, quietly instructing local health jurisdictions and vaccine providers to trust patients
Pharmaceutical industry
The global oncology clinical trials market is experiencing significant growth, driven by the increasing burden of cancer worldwide, the growing role of precision and personalized medicine for cancer treatment, and the presence of big outsourcing firms in the region. According to a recent report by ResearchAndMarkets.com, the market is
Pharmaceutical industry
The Allegheny Health Network has initiated a comprehensive COVID-19 vaccination campaign for children between the ages of 5 and 11, following the emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine series by the FDA and CDC. The network has released vaccine appointment slots for families and begun administering the
Pharmaceutical industry
The Biden administration has announced new vaccine rules for private businesses with 100 or more employees, certain healthcare workers, and federal contractors. The rules, set to take effect on January 4, require employees in these groups to receive two doses of Pfizer or Moderna's vaccine or one dose
Pharmaceutical industry
A significant milestone in the fight against COVID-19 has been reached, as the Food and Drug Administration's panel of independent advisors has recommended emergency use authorization for the Pfizer-BioNTech vaccine in children aged 5 to 11. This decision, pending formal approval from the FDA, would allow for widespread
Pharmaceutical industry
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have announced the expansion of COVID-19 vaccine booster doses, allowing for a mix-and-match strategy. CDC Director Rochelle Walensky, M.D., has endorsed recommendations from the Advisory Committee on Immunization Practices (ACIP) for the use of
Pharmaceutical industry
The pharmaceutical industry's powerful trade group, Pharmaceutical Research and Manufacturers of America (PhRMA), has launched a wide-ranging campaign to kill Democrats' sweeping drug price proposal, a crucial tool to reduce high drug prices. For months, PhRMA has spent millions on lobbying and TV ads warning that the
Pharmaceutical industry
Walmart and Midwestern grocer Hy-Vee have started offering COVID-19 booster shots from Moderna and Johnson & Johnson after the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) endorsed their use. According to Dr. John Wig, Walmart's chief medical officer, the company has authorized
Pharmaceutical industry
The global protein therapeutics market has exhibited moderate growth during 2015-2020, with an expected growth rate of around 6% during 2021-2026. The increasing prevalence of chronic medical ailments, rising awareness about protein therapeutics, and the development of novel recombinant proteins are driving the market growth. The COVID-19 pandemic has provided
Pharmaceutical industry
As the Centers for Disease Control and Prevention (CDC) released recommendations on who should receive an additional dose of the COVID-19 vaccine, major pharmacy chains such as CVS Pharmacy began rolling out Pfizer-BioNTech booster shots on September 24. This expansion includes individuals 65 years and older, residents in long-term care
Pharmaceutical industry
The COVID-19 pandemic has significantly transformed the post-pandemic marketplace, presenting both opportunities and challenges for the global healthcare nanotechnology (nanomedicine) market. A new market study published by Global Industry Analysts Inc. estimates that the market will reach $418.6 billion by 2026, growing at a compound annual growth rate (CAGR)
Pharmaceutical industry
The global orphan drugs market reached a value of $174.7 billion in 2020, driven by the increasing prevalence of rare genetic disorders and cancer. The market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2021 to 2026, driven by the development of
